Skip to main content

Table 6 Satisfaction evaluation for hair preservation at the end of CT (last rated CT-cycle) and with the scalp cooling treatment in VAS (0–100)

From: Successful reduction of alopecia induced by anthracycline and taxane containing adjuvant chemotherapy in breast cancer – clinical evaluation of sensor-controlled scalp cooling

Satisfaction with hair preservation
(Neo-) adjuvant CT mean sd median max min
all 71 25 75 100 8
EC 70 20 70 90 50
EC/Doc 71 28 80 100 8
FEC 75 20 75 100 30
FEC/Doc 57 24 60 85 15
Palliative CT 92 11 95 100 70
Satisfaction with scalp cooling treatment
(Neo-) adjuvant CT
all 73 26 80 100 1
EC 68 18 65 90 50
EC/Doc 71 28 80 100 1
FEC 82 18 80 100 20
FEC/Doc 65 25 70 100 10
Palliative CT 94 10 100 100 50